PriceTargets.com logo

Innovid - CTV Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $2.83
  • Forecasted Upside: -8.31%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$3.09 As of 12/23/2024 03:10 PM ET
▼ -0.08 (-2.52%)

This chart shows the closing price for CTV by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Innovid Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CTV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CTV

Analyst Price Target is $2.83
▼ -8.31% Downside Potential
This price target is based on 4 analysts offering 12 month price targets for Innovid in the last 3 months. The average price target is $2.83, with a high forecast of $3.00 and a low forecast of $2.50. The average price target represents a -8.31% upside from the last price of $3.09.

This chart shows the closing price for CTV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 4 investment analysts is to hold stock in Innovid. This rating has held steady since October 2024, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/2/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/30/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/29/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/28/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/26/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
11/23/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
12/23/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/22/2024Needham & Company LLCReiterated RatingBuy ➝ Hold$3.00 ➝ $3.00
11/21/2024Citizens JmpDowngradeStrong-Buy ➝ Hold
11/21/2024JMP SecuritiesDowngradeOutperform ➝ Market Perform
11/13/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$3.00 ➝ $3.00
8/6/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$3.00 ➝ $3.00
7/23/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$2.20 ➝ $2.50
7/12/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$3.00 ➝ $3.00
6/4/2024JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$3.00 ➝ $3.00
5/20/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$3.00
5/8/2024Needham & Company LLCBoost TargetBuy ➝ Buy$2.25 ➝ $3.00
4/16/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$1.60 ➝ $2.10
4/10/2024JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$3.00
2/28/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$1.50 ➝ $1.60
2/27/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$2.25
12/1/2023Needham & Company LLCBoost TargetBuy ➝ Buy$1.50 ➝ $2.25
11/9/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$1.40 ➝ $1.50
10/18/2023Needham & Company LLCLower TargetBuy ➝ Buy$3.00 ➝ $1.50
8/9/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$1.10 ➝ $1.40
7/24/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$3.00
3/16/2023JMP SecuritiesReiterated RatingMarket Outperform$5.00
3/6/2023Morgan StanleyLower TargetEqual Weight$2.40 ➝ $2.20
2/27/2023JMP SecuritiesLower TargetMarket Outperform$6.00 ➝ $5.00
1/18/2023Morgan StanleyLower TargetEqual Weight$2.70 ➝ $2.40
11/16/2022Evercore ISILower Target$4.00
11/11/2022Needham & Company LLCLower TargetBuy$6.00 ➝ $4.00
9/13/2022Morgan StanleyInitiated CoverageUnderweight$2.70
8/11/2022JMP SecuritiesLower TargetMarket Outperform$9.00 ➝ $6.00
2/25/2022Needham & Company LLCLower TargetBuy$10.00 ➝ $6.00
2/8/2022JMP SecuritiesReiterated RatingBuy$9.00
2/8/2022BMO Capital MarketsLower TargetOutperform$13.00 ➝ $8.00
1/5/2022JMP SecuritiesInitiated CoverageOutperform$11.00
12/28/2021Needham & Company LLCInitiated CoverageBuy$10.00
12/27/2021BMO Capital MarketsInitiated CoverageOutperform$13.00
12/17/2021Evercore ISIInitiated CoverageOutperform$10.00
(Data available from 12/23/2019 forward)

News Sentiment Rating

0.52 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 7 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
5/27/2024
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/26/2024
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/26/2024
  • 4 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/25/2024
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/24/2024
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/24/2024
  • 4 very positive mentions
  • 21 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/23/2024
  • 2 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/23/2024

Current Sentiment

  • 2 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Innovid logo
Innovid Corp. operates an independent software platform that provides ad serving, measurement, and creative services. It offers advertising services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV, and desktop TV environments to advertisers, publishers, and media agencies. The company serves consumer packaged goods, pharmaceutical and healthcare, retail, financial services, and automotive and technology industries; third party agencies; and publishers in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. Innovid Corp. was incorporated in 2007 and is headquartered in New York, New York.
Read More

Today's Range

Now: $3.09
Low: $3.08
High: $3.12

50 Day Range

MA: $2.39
Low: $1.63
High: $3.17

52 Week Range

Now: $3.09
Low: $1.25
High: $3.40

Volume

980,988 shs

Average Volume

784,065 shs

Market Capitalization

$458.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.3

Frequently Asked Questions

What sell-side analysts currently cover shares of Innovid?

The following Wall Street research analysts have issued research reports on Innovid in the last twelve months: Citizens Jmp, JMP Securities, Morgan Stanley, Needham & Company LLC, and TheStreet.
View the latest analyst ratings for CTV.

What is the current price target for Innovid?

0 Wall Street analysts have set twelve-month price targets for Innovid in the last year. Their average twelve-month price target is $2.83, suggesting a possible downside of 8.3%. JMP Securities has the highest price target set, predicting CTV will reach $3.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $2.50 for Innovid in the next year.
View the latest price targets for CTV.

What is the current consensus analyst rating for Innovid?

Innovid currently has 4 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CTV, but not buy more shares or sell existing shares.
View the latest ratings for CTV.

What other companies compete with Innovid?

Other companies that are similar to Innovid include Endava, Semrush, N-able, Certara and Integral Ad Science. Learn More about companies similar to Innovid.

How do I contact Innovid's investor relations team?

Innovid's physical mailing address is 89 MEDINAT HAYEHUDIM STREET, HERZLIYA L3, 4676672. The company's listed phone number is 212-966-7555 and its investor relations email address is [email protected]. The official website for Innovid is www.ion-am.com. Learn More about contacing Innovid investor relations.